Showing results (201-210 of 217) with videos related to
Sort By:
Pageof 22
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 22, 2008
Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistryHadi Yaziji, Clive R Taylor, Neal S Goldstein, et al.Virchows Archiv : an International Journal of Pathology|October 19, 2023
Analytical and clinical validation of PATHWAY Anti-HER-2/neu (4B5) antibody to assess HER2-low status for trastuzumab deruxtecan treatment in breast cancerCharo Garrido, Melissa Manoogian, Dhiraj Ghambire, et al.Cancer Discovery|February 5, 2014
Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphismsYibin Yang, Roland Schmitz, Joseph Mitala, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013
Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOPXin Huang, Bin Meng, Javeed Iqbal, et al.Blood|December 16, 2014
Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphomaJaveed Iqbal, Yulei Shen, Xin Huang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateAntonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.Archives of Pathology & Laboratory Medicine|October 9, 2013
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateAntonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisoneNathalie A Johnson, Graham W Slack, Kerry J Savage, et al.Nature|December 24, 2010
Oncogenically active MYD88 mutations in human lymphomaVu N Ngo, Ryan M Young, Roland Schmitz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Optimizing the Use of Gene Expression Profiling in Early-Stage Breast CancerHyun-Seok Kim, Christopher B Umbricht, Peter B Illei, et al.Pageof 22